Park Avenue Securities’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$717K Buy
10,643
+3,108
+41% +$207K ﹤0.01% 1113
2026
Q1
$473K Buy
7,535
+327
+5% +$22.8K ﹤0.01% 1127
2025
Q4
$478K Sell
7,208
-6,518
-47% -$421K ﹤0.01% 1110
2025
Q3
$924K Sell
13,726
-4,467
-25% -$354K 0.01% 906
2025
Q2
$1.59M Buy
18,193
+107
+0.6% +$8.39K 0.01% 598
2025
Q1
$1.24M Buy
18,086
+4,739
+36% +$387K 0.02% 537
2024
Q4
$1.04M Buy
13,347
+1,627
+14% +$120K 0.01% 743
2024
Q3
$786K Sell
11,720
-2,990
-20% -$246K 0.01% 782
2024
Q2
$1.67M Sell
14,710
-139
-0.9% -$17.6K 0.02% 475
2024
Q1
$2.06M Buy
14,849
+2,123
+17% +$267K 0.03% 409
2023
Q4
$1.58M Sell
12,726
-673
-5% -$68.8K 0.02% 446
2023
Q3
$1.25M Sell
13,399
-3,516
-21% -$396K 0.02% 474
2023
Q2
$2.17M Sell
16,915
-291
-2% -$35.2K 0.03% 299
2023
Q1
$2M Sell
17,206
-392
-2% -$43.9K 0.03% 294
2022
Q4
$1.99M Buy
17,598
+166
+1% +$18.2K 0.04% 310
2022
Q3
$1.4M Sell
17,432
-1,000
-5% -$84.7K 0.03% 347
2022
Q2
$1.37M Buy
18,432
+1,472
+9% +$134K 0.03% 363
2022
Q1
$2.17M Buy
16,960
+2,424
+17% +$265K 0.04% 262
2021
Q4
$1.95M Buy
14,536
+3,976
+38% +$571K 0.03% 283
2021
Q3
$1.44M Buy
10,560
+932
+10% +$118K 0.03% 302
2021
Q2
$1.03M Buy
9,628
+2,696
+39% +$259K 0.02% 377
2021
Q1
$623K Buy
6,932
+3,260
+89% +$306K 0.02% 514
2020
Q4
$339K Buy
+3,672
New +$328K 0.01% 633

Other funds holding DXCM

Park Avenue Securities's DXCM Position: Q2 2026 in Review

Park Avenue Securities increased its DexCom (DXCM) stake by 41% in Q2 2026, buying an estimated $207K and bringing the position to 10,643 shares worth $717K. The position accounts for ﹤0.01% of the portfolio, ranked #1113.

Park Avenue Securities first reported a position in DXCM in Q4 2020 and has held it in 23 quarters since. The position peaked at $2.17M in Q2 2023. 224 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Park Avenue Securities held 10,643 shares of DexCom worth $717K as of Q2 2026.
  • Park Avenue Securities bought 3,108 DexCom shares in Q2 2026, an estimated $207K.
  • DexCom made up ﹤0.01% of Park Avenue Securities's portfolio in Q2 2026, its #1113 holding.
  • Park Avenue Securities first reported a position in DexCom in Q4 2020 and has held it in 23 quarters since.
  • Park Avenue Securities's DexCom position peaked at $2.17M in Q2 2023.
  • 224 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.